IL133222A0 - Pharmaceutical compositions containing cinchonine dichlorohydrate - Google Patents

Pharmaceutical compositions containing cinchonine dichlorohydrate

Info

Publication number
IL133222A0
IL133222A0 IL13322298A IL13322298A IL133222A0 IL 133222 A0 IL133222 A0 IL 133222A0 IL 13322298 A IL13322298 A IL 13322298A IL 13322298 A IL13322298 A IL 13322298A IL 133222 A0 IL133222 A0 IL 133222A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
cinchonine
dichlorohydrate
containing cinchonine
Prior art date
Application number
IL13322298A
Other languages
English (en)
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Publication of IL133222A0 publication Critical patent/IL133222A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13322298A 1997-06-11 1998-06-08 Pharmaceutical compositions containing cinchonine dichlorohydrate IL133222A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707234A FR2764509A1 (fr) 1997-06-11 1997-06-11 Compositions pharmaceutiques contenant du dichlorhydrate de cinchonine
PCT/FR1998/001166 WO1998056383A1 (fr) 1997-06-11 1998-06-08 Compositions pharmaceutiques contenant du dichlorhydrate de cinchonine

Publications (1)

Publication Number Publication Date
IL133222A0 true IL133222A0 (en) 2001-03-19

Family

ID=9507852

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13322298A IL133222A0 (en) 1997-06-11 1998-06-08 Pharmaceutical compositions containing cinchonine dichlorohydrate
IL133222A IL133222A (en) 1997-06-11 1999-11-30 Pharmaceutical compositions containing cinchonine dihydrochloride and their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL133222A IL133222A (en) 1997-06-11 1999-11-30 Pharmaceutical compositions containing cinchonine dihydrochloride and their preparation

Country Status (14)

Country Link
US (1) US6528524B2 (zh)
EP (1) EP0986390B1 (zh)
JP (1) JP2002504109A (zh)
CN (1) CN1189174C (zh)
AT (1) ATE224716T1 (zh)
AU (1) AU740642B2 (zh)
CA (1) CA2295704A1 (zh)
DE (1) DE69808287T2 (zh)
DK (1) DK0986390T3 (zh)
ES (1) ES2184285T3 (zh)
FR (1) FR2764509A1 (zh)
IL (2) IL133222A0 (zh)
PT (1) PT986390E (zh)
WO (1) WO1998056383A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015041551A1 (en) * 2014-02-12 2015-03-26 Adam Mickiewicz University Application of cinchona alkaloid derivatives as cytotoxic compounds
US11066421B1 (en) * 2021-02-09 2021-07-20 Ares Pharmaceuticals, LLC Synthetic cinchona alkaloids against cancer
US11649232B2 (en) 2021-05-10 2023-05-16 Ares Pharmaceuticals, LLC Synthetic dimeric cinchona alkaloids against cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981003564A1 (en) 1980-05-27 1981-12-10 C Rose Drum pitch modulation
CA2081343C (fr) * 1991-02-25 2003-09-16 Bruno Chauffert Agents therapeutiques pour le traitement de la resistance multi-drogue dans les cas de cancer
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant

Also Published As

Publication number Publication date
US6528524B2 (en) 2003-03-04
CA2295704A1 (fr) 1998-12-17
ES2184285T3 (es) 2003-04-01
EP0986390A1 (fr) 2000-03-22
CN1189174C (zh) 2005-02-16
PT986390E (pt) 2003-01-31
ATE224716T1 (de) 2002-10-15
DE69808287T2 (de) 2003-06-26
AU740642B2 (en) 2001-11-08
IL133222A (en) 2006-08-01
EP0986390B1 (fr) 2002-09-25
DE69808287D1 (de) 2002-10-31
DK0986390T3 (da) 2003-01-27
FR2764509A1 (fr) 1998-12-18
AU7924498A (en) 1998-12-30
WO1998056383A1 (fr) 1998-12-17
JP2002504109A (ja) 2002-02-05
CN1259869A (zh) 2000-07-12
US20020091136A1 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
HU913497D0 (en) Process for the production of 3-(2h)-piridazinone-derivatives, and medical preparations containing such active agents
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
MX9706449A (es) Composicion farmaceutica para compuestos de piperidinalcanol.
SI0725779T1 (zh)
ZA954548B (en) Monoamine diamide thiol-containing metal chelating agents
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
ZA968956B (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
HUT50844A (en) Process for producing new 2'-halogen methylidene, 2'-ethenylidene and 2'-ethinyladenosine derivatives and pharmaceutical compositions comprising same as active ingredient
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
IL133222A0 (en) Pharmaceutical compositions containing cinchonine dichlorohydrate
PT80961B (en) Process for the preparation of new pharmaceutical compounds containing mixtures of 4,9-dihydro-4-(1-methyl-4-piperydilene)-10h-benzoý4,5¨-cycloheptaý1,2-b¨thyophene-10-one and antiasthmati c xantines as active ingredient
TW218011B (zh)
HRP940315B1 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
HU9302813D0 (en) Pharmaceutical compositions containing new benzimidazole derivatives and process for preparing the active ingredients
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
GEP20033054B (en) 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees